|Articles|February 1, 2001

Emerging Strategies in the Treatment of Gastroesophageal Reflux Disease
Volume 7
Issue 1 Suppl

Selected Abstracts

Articles in this issue

over 25 years ago

Article

Participating Faculty

over 25 years ago

Article

Introduction

over 25 years ago

Article

Beyond Heartburn: Extraesophageal Manifestations of Gastroesophageal Reflux Disease

over 25 years ago

Article

The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces Gastropathy

over 25 years ago

Article

Aggressive Acid Control: Minimizing Progression of Barrett's Esophagus

over 25 years ago

Article

How Far to Go? Screening and Surveillance in Barrett's Esophagus

over 25 years ago

Article

Debating the Role of Helicobacter pylori Infection

over 25 years ago

Article

Continuing Medical Education Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Selected Abstracts

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance

Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog

Active US Drug Shortages Rise for Third Straight Quarter

Medicaid MFN Pricing Could Save $8.6 Billion

Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD